Fonte: Cancer medicine. Unidade: FM
Assuntos: NEOPLASIAS COLORRETAIS, ESTUDOS DE COORTES, MORTALIDADE, SOBREVIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BALKRISHNAN, Rajesh et al. Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: a Medicare SEER cohort analysis. Cancer medicine, v. 10, n. 15, p. 5347-5357, 2021Tradução . . Disponível em: https://doi.org/10.1002/cam4.4088. Acesso em: 21 ago. 2024.APA
Balkrishnan, R., Desai, R. P., Narayan, A., Camacho, F. T., Flausino, L. E., & Chammas, R. (2021). Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: a Medicare SEER cohort analysis. Cancer medicine, 10( 15), 5347-5357. doi:10.1002/cam4.4088NLM
Balkrishnan R, Desai RP, Narayan A, Camacho FT, Flausino LE, Chammas R. Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: a Medicare SEER cohort analysis [Internet]. Cancer medicine. 2021 ; 10( 15): 5347-5357.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1002/cam4.4088Vancouver
Balkrishnan R, Desai RP, Narayan A, Camacho FT, Flausino LE, Chammas R. Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: a Medicare SEER cohort analysis [Internet]. Cancer medicine. 2021 ; 10( 15): 5347-5357.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1002/cam4.4088